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COMPLETION 
PNEUMONECTOMY: 
INDICATIONS AND 
OUTCOME 
Completion pneumonectomy has been associated with higher rates of morbid- 
ity and mortality and this is reflected in the selection of cases and the 
indications for the procedure. During a period of 14 years from January 1980 
to November 1993, 38 completion pneumonectomies were done by our surgical 
team, representing 5.1% of all pneumonectomies. There were 24 right and 14 
left completion pneumonectomies done in 26 male and 12 female patients with 
an average age of 61 years (range from 29 to 77 years). Lung malignancy 
accounted for 26 of these cases in which the indication included local 
recurrence in 10, second primary tumor in 9, malignancy that developed after 
resection for benign disease in 2, and pulmonary metastasectomy in 5 cases. 
Benign diseases were the indication in 12 cases: tuberculosis in 4, bronchiec- 
tasis in 4, aspergiliosis in 1, and postoperative complications in 3. Additional 
surgical procedures were necessary in 7 cases: chest wall resection with 
insertion of prosthesis in 3, thoracoplasty in 2, and omental flap in 2. There 
was I early postoperative death after 5 weeks from adult respiratory distress 
syndrome. There was no occurrence of bronchopleurai fistula, and the 18% 
associated morbidity rate was a result of bleeding necessitating reexploration 
in 3 cases, prolonged ventilation in 2, and chronic empyema in 2. Six of these 
complications (86%) occurred in the group with benign disease. Completion 
pneumonectomy can be done with an acceptable morbidity in selected patients. 
Careful technique is important o secure hemostasis and to avoid fistulas. The 
complication rate is higher when infective disease is involved. (J THORAC 
CARDIOVASC SURG 1995;110:1125-29) 
Khaled A1-Kattan, FRCS, and Peter Goldstraw, FRCS, 
London, United Kingdom 
T he indications for completion pneumonectomy that is, resection of the remaining lung tissue 
after partial pulmonary resection, have greatly in- 
creased with the wider use of bronchoplastic tech- 
niques, the management of early lung cancer with 
limited resection, and the increasing demand for 
pulmonary metastasectomy. The concept hat com- 
pletion pneumonectomy carries a higher mortality 
and morbidity than standard pneumonectomy 
should be reevaluated in light of the increasing 
number of cases in which completion pneumonec- 
tomy is indicated. In this paper we review our 
experience with this operation to study the different 
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indications for it and to evaluate the outcome when 
it is done. 
Patients and methods 
During a period of 14 years between January 1980 and 
December 1993, 38 completion pneumonectomies were 
done by our surgical team at the Royal Brompton Hospi- 
tal, Middlesex Hospital, and University College Hospital 
in London. This represented 5.1% of the 745 pneumonec- 
tomies done during the same period. There were 26 male 
and 12 female patients with an average age of 61 years 
(range 29 to 77 years). Right completion pneumonectomy 
was done in 24 cases and left completion pneumonectomy 
in 14. The indication for CP was malignant disease in 26 
and benign disease in 12 cases. 
In the group with malignant disease the indication for 
completion pneumonectomy included local recurrence in 
10 cases, a second primary tumor in 9, malignancy that 
developed after resection for benign disease in 2, and 
pulmonary metastasectomy in 5. Local recurrence was 
defined as a second lung malignancy with the same cell 
type, same anatomic site, and occurring within 2 years of 
the first operation. When there was residual tumor at the 
resected margin (bronchial stump) at the time of the 
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operation or when the bronchoscopic examination showed 
recurrence at the stump and the tumor was of the same 
cell type, the case was considered as local recurrence 
regardless of the time interval between the two opera- 
tions. In this group of cases of local recurrence (n = 10) 
there were four squamous cell carcinomas, three adeno- 
carcinomas, two bronchoalveolar carcinomas, and one 
large-cell carcinoma. Eight of the completion pneumonec- 
tomy procedures were done on the right side and two on 
the left after six upper lobectomies (4right and 2 left), one 
right lower lobectomy, one middle and lower bilobectomy, 
and one wedge excision of the right upper lobe. The 
disease stage at the first operation was T2 N2 in three 
patients, T2 N1 in three, T1 N1 in three, and T1 NO in one. 
The completion pneumonectomy was done after a mean 
interval of 18 months (range from 3 weeks to 4 years). At 
operation the stage of the cancer was T2 N2 in three 
patients, T2 N1 in two, T2 NO in two, T1 NO in one, and 
stump recurrence in two. 
A second primary tumor was defined as a second 
malignancy with a different cell type, different anatomic 
site, and occurrence after more than 2 years from the first 
malignancy in the absence of residual tumor at the first 
operation. In this group there were nine completion 
pneumonectomy operations (5 left and 4 right) after six 
upper lobectomies (3 right and 3 left), two left upper 
lobectomies, and 1 right basal segmentectomy. The mean 
disease-free interval for this group was 4.8 years (range 
from 2 to 8 years). The cell type of the tumor at 
completion pneumonectomy changed from adenocarci- 
noma in five, squamous cell carcinoma in three, and 
invasive carcinoid disease in one to squamous cell carci- 
noma in five, adenocarcinoma in three, and undifferenti- 
ated lung cancer in one at the second operation. 
Two patients underwent completion pneumonectomy 
after lung resection for benign disease. One patient had a 
lung abscess 12 years before for which a left upper 
lobectomy was done and returned with T2 NO squamous 
cell carcinoma involving the left lower lobe. The second 
patient had tuberculosis nvolving the left upper lobe and 
required lobectomy; after 12 years T2 N1 squamous cell 
carcinoma necessitated completion pneumonectomy. 
In the group with metastatic disease, the criteria for 
completion pneumonectomy included (1) reliable control 
of the primary tumor, (2) absence of other sites of distant 
metastasis, (3) no contralateral pulmonary metastases, 
and (4) preferably a reasonable disease-free interval be- 
tween the most recent pulmonary metastasectomy and the 
completion pneumonectomy. In this group there were five 
male patients with an average age of 39 years (range 28 to 
51 years). There were three right and two left completion 
pneumonectomy procedures and the operation was done 
as a second-phase operation in three patients, after me- 
dian sternotomy in two and after posterolateral thoracot- 
omy in 1. The completion pneumonectomy was a third- 
phase operation in one patient, after median sternotomy 
and posterolateral thoracotomy, and a fourth-phase oper- 
ation in one after median sternotomy and two posterolat- 
eral thoracotomies. The time interval between the most 
recent operation and the completion pneumonectomy was 
6 to 24 months with an average of 10 months. The primary 
malignancy was soft tissue sarcoma in three, osteosarcoma 
in one, and transitional cell carcinoma of the bladder in 
one. 
In the group with benign disease (n = 12) the indication 
for completion pneumonectomy was operative complica- 
tions after resection for lung malignancy in three patients. 
Two of these patients had narrowing of the bronchus 
intermedius after right upper lobectomy for T2 NO large- 
cell carcinoma in one and sleeve right upper lobectomy 
for small-cell carcinoma in the other. The narrowing was 
symptomatic and resistant to simple dilation and necessi- 
tated completion pneumonectomy 7 and 9 months later, 
respectively. The third patient had middle and lower 
bilobectomy for T2 N2 squamous cell carcinoma but an 
intrapulmonary abscess developed in the remaining lobe 
and completion pneumonectomy was done 3 weeks after 
the first operation. In the remaining nine patients in the 
benign group the completion pneumonectomy was done 
to deal with recurrence of the primary disease: four 
patients had tuberculosis, four had bronchiectasis, and 
one had aspergillosis. There were five male and four 
female patients with an average age of 61 years (range 54 
to 69 years). The time interval between the first and 
second operation ranged from 5 to 30 years with an 
average of 16 years. Surgical intervention i these patients 
was required because of hemoptysis in four, recurrent 
productive cough with chest infection in three, and infec- 
tion associated with empyema in two. 
Operative technique. In all 38 patients the selection 
criteria for completion pneumonectomy were the same as 
those for standard pneumonectomy. Although these pa- 
tients tend to have lower respiratory reserve the forced 
expiratory volume in 1 second in all patients was more 
than 1.5 L. Preoperative valuation included assessment 
of cardiac and renal function. In the group with malignant 
disease preoperative assessment of the mediastinal lymph 
nodes by computed tomographic (CT) scans with or 
without mediastinal lymph node biopsy were done to 
exclude gross N2 disease. All resections in this group were 
potentially curative and distant metastasis was excluded. 
Preoperative bronchoscopic examination was done for all 
patients and if the diagnosis was not confirmed an intra- 
operative frozen section was arranged. 
All 38 completion pneumonectomy operations were 
done by a uniform surgical technique. Prophylactic anti- 
biotics were given to all patients and posterolateral tho- 
racotomy was the standard surgical access. Extra time was 
spent to ensure complete hemostasis during lung mobili- 
zation. 
In cases with malignant disease routine meticulous 
lymph node dissection was done as part of our intraoper- 
ative restaging before the decision to perform resection 
was made. 
The bronchus was clamped with a crushing bronchial 
clamp in all cases and a hand suture technique with three 
layers of continuous Prolene suture (Ethicon, Inc., Som- 
erville, N.J.) was used to ensure a short bro~achial stump. 
This technique has been described before." In cases of 
stump recurrence or when the tumor was near the main 
bronchus, the open technique was applied. The stump was 
buried beneath the mediastinal structures. After hemosta- 
sis was secured the chest was closed. It is our routine not 
to drain the pneumonectomy space in standard pneumo- 
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nectomy or elective completion pneumonectomy, but if 
there was a risk of excessive bleeding as when completion 
pneumonectomy was done because of inflammatory dis- 
ease or as emergency procedure, a basal drain was used, 
and that was the case in 13 patients. Additional surgical 
procedures were required in seven cases. Three patients in 
whom completion pneumonectomy was done for metas- 
tasectomy required chest wall resection and the insertion 
of a chest wall prosthesis. In two patients who underwent 
completion pneumonectomy because of tuberculosis with 
an associated empyema, a limited thoracoplasty was 
added. In two patients who received completion pneumo- 
nectomy for tuberculosis and aspergilloma, an omental 
flap was used to cover the bronchial stump at the time of 
the operation. Elective mechanical ventilation and inten- 
sive care unit management after operation were not our 
routine practice. Eighteen of our patients were cared for 
after operation i  the intensive care unit for an average of 
30 (-+6) hours. Mechanical ventilation for an average of 8 
(_+2) hours was required in six patients. 
Results 
There was one in-hospital death for an operative 
mortality rate of 2.6% ~. This occurred in a 65-year- 
old man who had had a right upper lobectomy for 
tuberculosis complicated by bronchiectasis; 5 years 
after this he had massive hemoptysis and emergency 
completion pneumonectomy was done. The patient 
required ventilation of the lungs for 5 days after 
operation and the adult respiratory distress syn- 
drome developed, which led to his death 5 weeks 
later. 
Completion pneumonectomy was associated with 
considerable morbidity: seven patients (18%) had 
postoperative complications. Postoperative bleeding 
that necessitated reexploration occurred in three 
patients. Prolonged ventilation of the lungs for five 
and seven days, respectively, necessitated a trache- 
ostomy in two patients. In two patients, chronic 
empyema occurred after completion pneumonec- 
tomy and an associated fistula was excluded in both 
cases. There were no cases of bronchopleural fistula 
(BPF) in the 38 completion pneumonectomy cases. 
Minor complications included a raised hemidia- 
phragm in two patients and a right Horner's syn- 
drome in one. 
All patients were followed up for a mean period 
of 36 months (range 5 months to 14 years). In the 
group of patients who had metastasectomy (n = 5), 
over a mean follow-up period of 24 months (range 
12 to 48 months), three patients are alive with no 
residual tumor; the remaining two died at 7 and 14 
months after operation, respectively. The initial 
pulmonary metastasis developed in these patients 3
and 4 years before death, respectively. In the lung 
cancer group (n = 21), the mean follow-up period 
was 6 years (range 8 months to 12 years). The 
overall actuarial 3- and 5-year survivals were 40% 
and 23%, respectively. 
Discussion 
Completion pneumonectomy has become a more 
frequent herapeutic option in the field of thoracic 
surgery. In 1988, McGovern and colleagues 2 re- 
ported from Mayo Clinic 113 cases of completion 
pneumonectomy with a mortality rate of 12.4% and 
an associated morbidity rate of 38.1%. Others re- 
ported an operative mortality rate of 10% and 
morbidity rate of 27% with actuarial 5-year survivals 
of 88% and 33% when completion pneumonectomy 
was done for benign and malignant diseases, respec- 
tively. 3
The indications for completion pneumonectomy 
have increased with the increasing demand for 
pulmonary metastasectomy and the longer survival 
of patients with early-stage lung cancer who have 
been previously treated with limited resection. 
Those patients howed a tendency for the develop- 
ment of a second primary lung cancer after a 5-year 
disease-free period. 4 The good results achieved in 
patients with several primary lung cancers may make 
completion pneumonectomy a more frequent op- 
t ion) The complications of sleeve resection include 
strictures and dehiscence, which can occur in up to 
13.1% of cases requiring completion pneumonecto- 
my. 6 In these cases endobronchial stents can salvage 
the remaining lung parenchyma. 7 
In our series we had only one operative death 
caused by respiratory failure in a patient with tuber- 
culosis. This was comparable to the risk of standard 
pneumonectomy. We have previously studied the 
hospital mortality after pulmonary resection, s In 
that study the pneumonectomy rate was 41.3% of all 
pulmonary resections with an in-hospital mortality 
rate of 6.7%. 8 
The associated morbidity occurred mainly in 
those patients who underwent completion pneumo- 
nectomy for benign disease (6 of 7 patients). Dense 
inflammatory adhesions and the consequences of 
the longstanding benign disease add greatly to the 
technical problems of completion pneumonectomy 
in these cases. Bleeding is a major postoperative 
complication and every effort should be made to 
secure hemostasis before closure. Extrapleural dis- 
section, in comparison with intrapleural dissection, 
increases this risk especially when inflammatory 
conditions are involved. Empyema in a pneurnonec- 
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tomy space is a life-threatening complication and 
prevention is the best treatment. In cases in which 
empyema carries a higher risk, such as in elderly 
patients with infective pathologic onditions, addi- 
tional surgical procedures might be advisable. Lim- 
ited thoracoplasty or the use of omental or muscle 
flaps to fill the hemithorax at the time of the 
operation can reduce this risk. The most common 
complication after completion pneumonectomy is 
respiratory failure: preoperative selection of the 
patients and good postoperative care are essential. 
Respiratory failure was responsible for our postop- 
erative death and for two cases of prolonged venti- 
lation and the insertion of postoperative tracheos- 
tomy. 
We did not have any occurrences of BPF in the 38 
cases: the use of a uniform suture technique and 
burying the bronchial stump are our routine prac- 
tices in all pneumonectomies. In our institution, the 
rate of BPF after pneumonectomy has been 1.6% 
for the past 14 years (7 of 746) and the most recent 
fistula occurred in 1986.1 
Although completion pneumonectomy forpulmo- 
nary metastasectomy was done as a third- or fourth- 
phase operation, it was not associated with any 
morbidity. This can be explained by the facts that 
those patients had a younger average age and that 
there was minimal risk of infection. 9 
The definition of a second primary tumor or 
recurrence of the original tumor is not yet univer- 
sally accepted. 1°The consideration of 2 years as the 
time limit after which a similar cell type tumor will 
be considered a second primary tumor is controver- 
sial. 11 We had a case in which the bronchial stump 
was involved with the first tumor and the patient was 
in a program of routine bronchoscopic examinations 
for 4 years when he had evidence of stump recur- 
rence. This makes the treatment of patients who 
show positive tumor at the resected bronchial mar- 
gin more difficult: the choices are either reexplora- 
tion and performance of completion pneumonec- 
tomy or close follow-up by periodic examination. 
Our practice is to send the bronchial stump as a 
separate specimen for histologic examination, and if 
the tumor is found to be close to the resected margin 
the bronchial stump is sent for frozen section to 
obtain an intraoperative histologic diagnosis. No 
cases of positive findings from the stump were 
reported in our hospital and the two cases of stump 
recurrence were referred from another hospital. 
There were more local recurrences in the patients 
with adenocarcinoma and with mediastinal lymph 
node involvement compared with those in the other 
patients, but the number was too small to show 
statistical significance. On the other hand when 
completion pneumonectomy was done because of a 
second primary tumor there were more cases of 
squamous cell carcinoma with nodal negative patho- 
logic findings at the first operation. In all cases done 
at our hospital either as the first pulmonary resec- 
tion or when completion pneumonectomy was done 
for malignancy careful preoperative staging was 
undertaken with CT scanning and selective use of 
mediastinal exploration. 12 In cases of completion 
pneumonectomy we tend to rely on the CT scan 
inasmuch as repeat mediastinoscopy is not reliable 
in our experience. The prevalence of local recur- 
rence is variable and the value of routine extensive 
mediastinal lymph node sampling in accurate stag- 
ing and in improving survival or reducing the prev- 
alence of local recurrence is not yet clear. Curative 
resection should be aimed for in all cases of com- 
pletion pneumonectomy and this may necessitate 
further resection: in our series chest wall resection 
with insertion of a prosthesis was necessary in two 
cases. Preoperative assessment and planning in 
these cases reduces the postoperative complica- 
tions.13, 14 
The surgeon should be aware that patients who 
had previous pulmonary resection for benign dis- 
ease are still at risk for the development of lung 
malignancy. Although some benign and malignant 
diseases hare common symptoms, careful clinical 
and radiologic examination should be done to ex- 
clude malignancy especially in elderly patients with 
a history of smoking. 
The time interval between the first operation and 
the need for completion pneumonectomy varies 
according to the underlying pathologic ondition: it 
is shorter with local recurrence and longer when 
benign diseases or second primary tumors are in- 
volved. 
The value of completion pneumonectomy is also 
related to the long-term results, especially when 
malignant diseases are involved. In the patients 
having metastasectomy our previous experience 
showed that in selected patients with the criteria 
described previously good long-term results can be 
achieved. Three of the five patients are alive and 
tumor-free more than 4 years from the initial pul- 
monary involvement. In the cancer group survival is 
related to the stage of the disease and although the 
number of patients in each stage was small the 
overall 5-year survival after completion pneumonec- 
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tomy was similar to the survival after the first 
operation. 
We conclude that with careful selection of pa- 
tients undergoing completion pneumonectomy an 
operative mortality similar to that of standard pneu- 
monectomy can be achieved. Completion pneumo- 
nectomy for benign infective problems is associated 
with higher morbidity and a greater level of preop- 
erative fitness and careful preparation are necessary 
to keep the operative risk acceptable. Additional 
procedures uch as thoracoplasty or omental flaps 
have proved useful. In dealing with malignancy as a 
recurrence or as a second primary tumor, an aggres- 
sive approach with completion pneumonectomy in 
selected patients as a curative procedure can offer 
good long-term survival. Completion pneumonec- 
tomy can also be done safely even as a third- or 
fourth-phase operation in patients with pulmonary 
metastasis. 
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